Chief Financial Officer · CorMedix Inc. (CRMD)

Matthew David

A named executive officer of CorMedix in every fiscal year CompBrief holds from FY2020 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,088,025

Salary $409,125Stock awards $173,500

FY2023: $1,031,150

3rd of 4 named executive officers at CorMedix by FY2024 total.

4 named officers on file for CorMedix, FY2024

Matthew David’s pay file — $29

  • 5 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CorMedix’s whole pay program stands against its peers

  • CorMedix’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CRMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Matthew David’s full pay file as a PDF — free

More than this page: up to 10 years of Matthew’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Matthew David compensation by year

CorMedix Summary Compensation Table · all 5 fiscal years held
In US dollars, as CorMedix reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024
Salary$209,423$351,923$393,462$389,135$409,125
Bonus$0$75,900$0$0$0
Stock awards$0$0$0$0$173,500
Option awards$768,386$951,895$305,900$433,875$279,670
Non-equity incentive$99,000$0$389,485$156,000$171,171
Pension and deferred compensation$0$0$0$0$0
All other$20,866$43,584$47,697$52,140$54,559
Total$1,097,675$1,423,302$1,136,544$1,031,150$1,088,025

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CorMedix Inc. DEF 14A filed April 28, 2025, accession 0001213900-25-036108, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CorMedix Inc. filed document, accession 0001213900-25-036108. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$1.1M
$1.4M
$1.1M
$1.0M
$1.1M
FY20
FY21
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
PSU37,500$303,750—
Option62,500—$4.43
Option25,000—$4.03
Option75,000—$3.47
Option62,500—$4.43

Per the Outstanding Equity Awards at Fiscal Year-End table in CorMedix Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

CorMedix’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Joseph TodiscoChief Executive Officer$2,359,908
Elizabeth HurlburtExecutive Vice President, Chief Clinical Strategy and Operations Officer$1,135,365
Matthew David · this pageChief Financial Officer$1,088,025
Beth Zelnick KaufmanExecutive Vice President, Chief Legal/Compliance Officer & Corp. Secretary$714,352

The full CorMedix compensation record

free company brief

This page is one person within CorMedix's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CorMedix's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Matthew David's compensation dossier · One-time report. No refunds.